Continuous positive airway pressure and surfactant

Area of Science:

• Neonatal Medicine
• Pediatric Pulmonology
• Respiratory Care

Background:

• Nasal continuous positive airway pressure (nCPAP) is a primary respiratory support for preterm infants, known as the 'Scandinavian Model'.
• Mechanical ventilation poses risks to immature lungs, with cohort studies linking higher nCPAP use to lower bronchopulmonary dysplasia rates.
• Evidence from large randomized controlled trials comparing nCPAP and mechanical ventilation is limited.

Purpose of the Study:

• To review the history, current knowledge, and techniques of nCPAP and surfactant therapy in preterm infants.
• To discuss the evolution and application of respiratory support strategies for neonatal respiratory distress syndrome.

Main Methods:

• This is a review article, synthesizing existing literature and clinical experience.
• Discussion includes the development and application of nCPAP and surfactant administration techniques.
• Focus on evidence supporting nCPAP and surfactant therapy, including the INSURE method.

Main Results:

• nCPAP is an established and effective treatment for respiratory distress syndrome.
• The INSURE technique allows surfactant administration during nCPAP, reducing the need for mechanical ventilation.
• Cohort studies suggest a benefit of nCPAP over mechanical ventilation in reducing bronchopulmonary dysplasia.

Conclusions:

• nCPAP is a valuable tool in neonatal respiratory support.
• The INSURE method enhances surfactant delivery during nCPAP, offering a less invasive alternative to mechanical ventilation.
• Further randomized controlled trials are needed to definitively establish the superiority of nCPAP-based strategies.